The health technology assessment body for England, the National Institute for Health and Care Excellence, has this week issued several positive recommendations for the funding of medicines on the National Health Service.
One of them is Sanofi’s Sarclisa (isatuximab), the first monoclonal antibody therapy to be approved for marketing in the...








